Top NSE Movers by Sector

Successful turnaround strategy showing results with 5G and network services revenue growing 25% QoQ.

Turnaround plans gaining momentum with sequential revenue growth of 3.2% in Q3, first positive growth in 4 quarters.

Major deal announcement with Fortune 500 company worth $1.5 billion over 5 years for digital transformation.

Strong Q3 earnings beat expectations with 12% YoY revenue growth driven by increased digital transformation deals.

Strong products & platforms revenue growth of 8.2% driven by DWS (Digital Workplace Services) and Cloud Native Labs.

US FDA approval for key specialty drug in dermatology segment, expected to generate $400 million in annual revenue.

Record quarterly performance with EBITDA margin of 38%, driven by high-margin API exports and new custom synthesis contracts.

Strong growth in respiratory franchise with new combo therapy gaining market share; trade generics business in US showing recovery.

Launched authorized generic for blockbuster diabetes drug in US market with 180-day exclusivity, expected to generate $150 million.

Turnaround story gaining traction with US business stabilizing and European operations showing strong growth of 18%.

Microfinance portfolio stress contained; vehicle finance showing strong revival with disbursements up 22% QoQ.

Strong retail loan growth of 20% YoY; asset quality showing marked improvement with slippage ratio declining.

Post-merger integration with HDFC Ltd showing strong synergies; NIMs improving with deposit growth outpacing advances.

Stellar Q3 results with net profit up 16% YoY; announced 1:5 bonus issue and significant dividend.

Recovery in credit growth momentum after regulatory actions resolved; announced acquisition of fintech startup for digital expansion.

Brent prices rallied and ONGC reported best realization in 10 quarters with higher gas output.

New PPA signing for 1.5 GW hybrid project and debt refinancing at lower rates boosted sentiment.

Renewable capacity crossed 3 GW and power demand remained elevated across regions.

Won three interstate transmission projects and announced dividend payout.

Energy and retail divisions delivered record EBITDA; Jio's tariff hike added to optimism.

Prepared foods and beverages delivered double-digit growth; company announced capex for new plant.

Health supplements and home care segments outperformed aided by new product launches.

Jewellery segment delivered 21% growth; watches and wearables saw strong festive demand.

Parachute and Saffola brands registered healthy volume growth aided by pricing actions.

Rural demand revival and price hikes in home care aided margin expansion.

New project launches in NCR and Bengaluru achieved record first-week bookings.

Affordable housing sales in MMR and Pune remain robust with strong cash flows.

Launched luxury project in Gurugram with ₹8,000 crore gross development value and strong bookings.

Retail consumption remains elevated with mall footfalls and rental income at all-time highs.

Premium residential launch in Goregaon West sold out 80% inventory in first weekend.